Lay Summary
Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
This study brought together the available evidence from around the world to help understand better how often PSC recurs after liver transplantation and also to identify factors associated with recurrence.
Read MoreA Blood “Fingerprint” of PSC Severity and Associated Cholangiocarcinoma
A research study looking at whether molecules circulating in the blood carry a “fingerprint” of what is happening in PSC -explained by Dr Ghada Nouairia.
Read MoreA Biopsychosocial Approach To Fatigue In PSC
Biological and psychological factors interact in fatigue, offering new possibilities for targeted management.
Read MorePredicting Disease Progression (Vitamin B6)
New research shows vitamin B6 levels predict primary sclerosing cholangitis disease progression.
Read MoreFibrate Therapy Tested For PSC
Could fibrates offer new hope for managing PSC?
Read MorePredicting PSC with a Multi-Biomarker Model
New multi-biomarker blood test model predicts transplant-free survival with high accuracy in PSC.
Read MoreAcute Cholangitis Survey Update
A global survey reveals how acute cholangitis symptom patterns directly predict recovery times.
Read MoreA pilot study reveals blocking the IL-17 pathway is safe and feasible for primary sclerosing cholangitis
A pilot study reveals blocking the IL-17 pathway is safe and feasible for primary sclerosing cholangitis.
Read MoreVolixibat Announcement at EASL Congress 2026
The latest results from the VISTAS trial to reduce itch in PSC.
Read MoreVISTAS Phase 2b Trial Results May 2026
New trial data shows volixibat significantly reduces severe itch for people with PSC.
Read More